.png){kind=logo}
Meet MiniMed
Experience the #1 insulin pump in preventing highs and lows based on user satisfaction,1 and our InPenTM Smart insulin pen that sends data to the MiniMed GoTM app, automating insulin dose tracking.*
It’s called MiniMedTM 780G and it has improved my quality of life tremendously.
Nicole
MiniMedTM 780G system user
Our Insulin management solutions
INSULIN PUMP THERAPY
Self-adjusting insulin pump
The MiniMedTM 780G system automatically corrects glucose levels every 5 minutes based on real-time CGM readings to optimise Time in Range*. This means freedom to eat what and when you want, more restful nights with fewer beeps. That`s less time needing to think about diabetes.
The pump system also offers a small, 15-day sensor and 7-day infusion set, for longer wear.
* Refers to SmartGuardTM technology, individual results may vary.
Fewer injections compared to MDI
Helps to reach 80% Time in range2
MULTIPLE DAILY INJECTION THERAPIES
MiniMed Go system
MiniMed GoTM is the only smart MDI system that continuously monitors glucose, proactively notifies you when you need more insulin and recommends a correction dose.3,4,¶
It combines the power of the latest innovation in continuous glucose monitoring (CGM), Instinct Go, made by Abbott, with the InPenTM Smart Insulin Pen and the MiniMed GoTM app.
Discover WeCare
Offers personalised onboarding programs and 24/7 hour support
About us
MiniMed is the complete insulin delivery company. Built around one belief: that technology should ease the burden of diabetes. So that every day is a better day.
Days when diabetes fades into the background and life takes the lead. Joyful, messy, fully lived days — when things feel lighter, easier, more possible. Those are the days we’re here to make real.
Information contained herein is not medical advice and should not be used as an alternative to speaking with your doctor. Discuss indications, contraindications, warnings, precautions, potential adverse events and any further information with your healthcare professional. Please consult your healthcare professional for a full list of benefits, indications, precautions, clinical results and other important medical information that pertains to the therapy or products discussed. See the device manuals for detailed information regarding the instructions for use, indications, contraindications, warnings, precautions and potential adverse events. For further information, contact your local MiniMed representative.
References
- Adults, T1 and parents of children with T1 diabetes < 18 years were surveyed based on their experience with GuardianTM 4 sensor.
- MiniMed data on file: MiniMedTM 780G data uploaded voluntarily by 12.870 users in EMEA to CareLinkTM Personal, from 27 August 2020 to 22 July 2021. Mean 80% TIR reached by 1.784 users using MiniMedTM 780G with recommended settings of 2 hours active insulin time and 100 mg/dL (5.5 mmol/L) as glucose target for at least 90% of the time.
- MiniMedTM Go System User Guide. https://www.minimed.com/content/dam/documents/en-us/MiniMed-Go-US-app-manual.pdf (Accessed April 2026).
- NovoPen® 5 User Guide. https://www.novonordisk.com/content/dam/nncorp/global/en/our-products/pdf/instructions-for-use/novopen-5/NovoPen5-UK.pdf (Accessed April 2026).
* Proper phone, pairing, connectivity and settings required; some manual logging may also be needed. Incorrect dosing and serious injury can occur without proper setup. See user guide for full details.
MC-DBA-2600036© 2026 MiniMed and MiniMed logo are trademarks of MiniMed. The sensor shape and appearance, Abbott and “a” logo are marks and/or designs of the Abbott group of companies in various territories and used under licence. Sensor image © 2026 Abbott. *Third–party brands are trademarks of their respective owners.